Home › SEC Filings › Insider Cluster Activity
Insider Cluster Activity
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| APGE | CLUSTER | neutral | 4/10 | Three corporate insiders at Apogee Therapeutics, including the CEO, CFO, and CMO, sold shares totaling $1.77 million ove | Apr 10, 2026 |
| UTHR | CLUSTER | mixed | 5/10 | Three corporate insiders at United Therapeutics, including CEO Martine Rothblatt and CFO James Edgemond, conducted open- | Apr 10, 2026 |
| IMVT | CLUSTER | neutral | 3/10 | Two Immunovant executives sold shares in open-market transactions totaling $522K, while multiple insiders received non-c | Apr 10, 2026 |
| RXRX | CLUSTER | neutral | 3/10 | Two directors at Recursion Pharmaceuticals sold a combined $217K in shares over a 7-day window, with no open-market buyi | Apr 8, 2026 |
| AVTX | CLUSTER | neutral | 4/10 | Two C-suite executives at Avalo Therapeutics, the CFO and Chief Medical Officer, sold shares worth $177K in the past wee | Apr 8, 2026 |
| KNSA | CLUSTER | mixed | 5/10 | Kiniksa Pharmaceuticals insiders executed a cluster of transactions over a 7-day window, including option exercises and | Apr 8, 2026 |
| PCVX | CLUSTER | neutral | 3/10 | Two Vaxcyte executives sold shares in the past week, including COO Jim Wassil selling $82K and SVP Elvia selling $180K a | Apr 8, 2026 |
| PTCT | CLUSTER | bearish | 5/10 | Three senior executives at PTC Therapeutics sold shares in a concentrated 7-day window, including a $2.71M open-market s | Apr 8, 2026 |
| LODE | CLUSTER | bullish | 6/10 | Two Comstock Inc. insiders, including the CFO, purchased $95K of stock in open-market transactions on March 30, 2026, sh | Apr 8, 2026 |
| INSM | CLUSTER | bearish | 7/10 | Two C-suite executives at INSMED Inc sold shares in early April, generating $4.06M in open-market proceeds. CEO Lewis Wi | Apr 8, 2026 |
| UTHR | CLUSTER | neutral | 3/10 | Three top executives at United Therapeutics, the CEO, CFO, and General Counsel, sold a combined $376K in shares over a 7 | Apr 8, 2026 |
| NUVL | CLUSTER | bearish | 7/10 | Nuvalent CEO and CFO sold shares worth $1.79M in a coordinated cluster over the past week, with the CEO selling $1.17M a | Apr 8, 2026 |
| CYTK | CLUSTER | bearish | 6/10 | Three corporate insiders at Cytokinetics sold shares in the past week, totaling $964K in open-market dispositions. CEO R | Apr 8, 2026 |
| OABI | CLUSTER | neutral | 2/10 | Two C-suite executives at OmniAb, the CFO and Chief Legal Officer, each sold a small number of shares in open-market tra | Apr 7, 2026 |
| VIR | CLUSTER | bearish | 6/10 | Vir Biotechnology's CEO and a board director collectively sold $864K worth of shares in the past week, with the CEO acco | Apr 7, 2026 |
| UTHR | CLUSTER | neutral | 4/10 | Four insiders at United Therapeutics sold a combined $1.18 million in stock over a one-week window, including notable op | Apr 7, 2026 |
| ALT | CLUSTER | neutral | 3/10 | Three corporate insiders at Altimmune, Inc. purchased shares in the open market over a 7-day period, including the CEO a | Apr 6, 2026 |
| WLK | CLUSTER | bearish | 6/10 | Two Westlake Corp executives, the CFO and a senior segment head, sold shares worth $2.31M in late March 2026, just days | Apr 6, 2026 |
| SYRE | CLUSTER | bearish | 6/10 | Two key executives at Spyre Therapeutics, the CFO and CMO, sold a combined $703K in open-market transactions on April 1, | Apr 3, 2026 |
| APGE | CLUSTER | bearish | 7/10 | Two Apogee Therapeutics insiders, the CFO and CMO, sold a combined $303K in stock within a week of a $350M public offeri | Apr 3, 2026 |
| NUVL | CLUSTER | neutral | 3/10 | Three Nuvalent executives, including the CFO and Chief Development Officer, sold shares in a coordinated cluster totalin | Apr 3, 2026 |
| DYN | CLUSTER | neutral | 3/10 | A mixed insider trading cluster at Dyne Therapeutics shows CFO Erick Lucera selling $107K in shares while Director Brian | Apr 3, 2026 |
| INSM | CLUSTER | bearish | 5/10 | Two C-suite executives at Insmed sold shares in the past week, generating $4.06 million in total proceeds. The sales wer | Apr 3, 2026 |
| AVTX | CLUSTER | neutral | 3/10 | Two C-suite executives at Avalo Therapeutics, the CFO and CMO, sold a combined $19K in open-market transactions within a | Apr 3, 2026 |
| CGEN | CLUSTER | neutral | 3/10 | Compugen CEO Ophir Eran sold $12.4K of stock and exercised two tranches of options, one at zero cost and another at $0.8 | Apr 3, 2026 |
| ANAB | CLUSTER | bearish | 7/10 | Two corporate insiders at AnaptysBio sold shares worth $731K within a 7-day window, including CEO Daniel Faga and Direct | Apr 1, 2026 |
| PCSA | CLUSTER | bullish | 6/10 | Multiple insiders at Processa Pharmaceuticals, including the CEO, CFO, and other C-suite executives, collectively purcha | Apr 1, 2026 |
| IMNM | CLUSTER | mixed | 5/10 | Immunome Inc. saw mixed insider activity with CEO Clay Siegall purchasing $501K of stock while Director Philip Wagenheim | Apr 1, 2026 |
| CYTK | CLUSTER | bearish | 6/10 | Two top executives at Cytokinetics, including CEO Robert Blum, sold shares in a coordinated 7-day window, generating $73 | Apr 1, 2026 |
| NUVL | CLUSTER | bearish | 7/10 | Three C-suite executives at Nuvalent sold a combined $1.71M in shares over a 7-day period, including CFO Alexandra Balco | Apr 1, 2026 |